VERA Klasse A Vera Therapeutics, Inc. - Class A Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 5, 2026 10-K/10-Q Aug 10, 2026
$29,56
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$23,0552-Wochen-Tief
$56,0552-Wochen-Hoch
P/E
-10.9
EPS
$-4.66
Ihre Abzeichen
52W-Spanne
$23–$56
Analystenbewertung
BUY
Kursziel
$78
P/E
-10.9
ROE
-55.9%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
VERA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$29.56
P/E
-10.9
EPS
$-4.66
ROE
-55.9%
52W-Spanne
$23–$56
VERA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-4.662021-12-31 → 2025-12-31
Freier Cashflow$-242M2022-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | VERA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -10.95-Jahres-Durchschnitt ≈-10.0 | ≈-10.0 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | VERA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -43.1%5-Jahres-Durchschnitt ≈-54.4% | ≈-54.4% | -40.3% | Schwach | |
| ROE | -55.9%5-Jahres-Durchschnitt ≈-63.2% | ≈-63.2% | -54.5% | Schwach | |
| ROIC | -52.2%5-Jahres-Durchschnitt ≈-69.8% | ≈-69.8% | -52.2% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | VERA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 10.95-Jahres-Durchschnitt ≈12.5 | ≈12.5 | 13.0 | Unterdurchschnittlich | |
| Quick Ratio | 13.45-Jahres-Durchschnitt ≈12.1 | ≈12.1 | 6.6 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-14.3%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 3, 2026 | $-1.52 | $-1.61 | 5.5% |
| 31. März 2026 | $-1.69 | $-1.35 | -24.9% | |
| 31. Dezember 2025 | $-1.39 | $-1.31 | -6.3% | |
| 30. September 2025 | $-1.26 | $-1.16 | -8.8% | |
| 30. Juni 2025 | $-1.20 | $-0.84 | -43.2% | |
| 31. März 2025 | $-0.81 | $-0.75 | -8.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $215M | $126M | $78M | $69M | $22M | $45M | |
| SG&A Expense | $100M | $41M | $24M | $22M | $12M | $4M | |
| Operating Expenses | $315M | $167M | $102M | $91M | $34M | $52M | |
| Operating Income | $-315M | $-167M | $-102M | $-91M | $-34M | $-52M | |
| Interest Expense | · | · | $4M | $992.0K | $20.0K | $166.0K | |
| Interest Income | $24M | $21M | $8M | $2M | $15.0K | $8.0K | |
| Other Non-op | $16M | $15M | $6M | $2M | $2M | $-1M | |
| Pretax Income | $-300M | $-152M | $-96M | $-89M | $-33M | $-53M | |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $-1.0K | |
| Net Income | $-300M | $-152M | $-96M | $-89M | $-33M | $-53M | |
| EPS (Basic) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | · | |
| EPS (Diluted) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | · | |
| Shares (Basic) | 64,233,814 | 55,326,680 | 42,707,072 | 26,570,676 | 13,435,706 | · | |
| Shares (Diluted) | 64,233,814 | 55,326,680 | 42,707,072 | 26,570,676 | 13,435,706 | · | |
| EBITDA | $-315M | $-167M | $-106M | $-92M | $-34M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $355M | $93M | $46M | $43M | $80M | $54M | |
| Short-term Investments | $360M | $548M | $115M | $71M | $0 | · | |
| Prepaid Expense | $14M | $10M | $11M | $11M | $3M | $557.0K | |
| Other Current Assets | $3M | $1M | $2M | $719.0K | $480.0K | $392.0K | |
| Current Assets | $729M | $651M | $172M | $126M | $83M | $54M | |
| PP&E (Net) | $1M | $960.0K | $92.0K | $51.0K | $0 | · | |
| Other Non-current Assets | $6M | · | · | · | · | · | |
| Total Assets | $735M | $656M | $176M | $131M | $84M | $55M | |
| Accounts Payable | $22M | $8M | $11M | $12M | $1M | $909.0K | |
| Accrued Liabilities | $32M | $16M | $9M | $11M | $6M | $535.0K | |
| Current Liabilities | $53M | $25M | $22M | $26M | $8M | $2M | |
| Capital Leases | $2M | $2M | $1M | $4M | $0 | · | |
| Other Non-current Liabilities | $2M | · | · | · | · | · | |
| Total Liabilities | $130M | $79M | $74M | $55M | $14M | $4M | |
| Long-term Debt | $75M | $51M | $50M | $25M | $5M | $0 | |
| Common Stock | $71.0K | $64.0K | $44.0K | $28.0K | · | · | |
| Retained Earnings | $-761M | $-461M | $-309M | $-213M | $-124M | $-91M | |
| AOCI | $786.0K | $393.0K | $251.0K | $-224.0K | $0 | · | |
| Stockholders' Equity | $605M | $577M | $102M | $77M | $70M | $-89M | |
| Liabilities + Equity | $735M | $656M | $176M | $131M | $84M | $55M |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $468.0K | $105.0K | $21.0K | $-846.0K | $176.0K | $251.0K | |
| Stock-based Comp | $38M | $21M | $11M | $9M | $3M | $331.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | $0 | $3M | |
| Other Non-cash | $20M | $-3M | $-4M | $13M | $6M | · | |
| Operating Cash Flow | $-241M | $-135M | $-92M | $-68M | $-24M | $-35M | |
| CapEx | $630.0K | $972.0K | $63.0K | $62.0K | $0 | $99.0K | |
| Investing Cash Flow | $194M | $-425M | $-39M | $-71M | $-4M | $-42.0K | |
| Stock Issued | · | · | · | $2M | $0 | · | |
| Stock Repurchased | $0 | $13.0K | $0 | · | · | · | |
| Net Stock Activity | $0 | $-13.0K | · | $2M | $51M | · | |
| Financing Cash Flow | $309M | $607M | $134M | $102M | $54M | $85M | |
| Net Change in Cash | $262M | $47M | $2M | $-36M | $26M | $50M | |
| Taxes Paid | $17.0K | $1.0K | $1.0K | · | · | · | |
| Free Cash Flow | $-242M | $-136M | $-92M | $-68M | · | · | |
| Levered FCF | · | · | $-96M | $-69M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -43.1% | -36.6% | -62.5% | -82.8% | -47.2% | · | |
| ROE | -55.9% | -35.1% | -85.2% | -97.5% | -42.1% | · | |
| ROIC | -52.2% | -29.0% | -100.3% | -118.2% | -49.4% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 13.6 | 25.7 | 7.7 | 4.9 | 10.7 | · | |
| Quick Ratio | 13.4 | 25.3 | 7.2 | 4.5 | 10.4 | · | |
| Interest Coverage | · | · | -26.9 | -91.6 | -1720.1 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash Flow / Share | $-3.75 | $-2.43 | $-2.16 | $-2.54 | · | · | |
| EPS (TTM) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-300M | $-152M | $-96M | $-89M | $-33M | · | |
| P/E | -10.9 | -15.4 | -6.8 | -5.8 | -11.0 | · | |
| Earnings Yield | -9.2% | -6.5% | -14.6% | -17.3% | -9.1% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $60M | $86M | $59M | $56M | $58M | $41M | $33M | $40M | $29M | $23M | $16M | $16M | $25M | $27M | $20M | $10M | |
| SG&A Expense | $52M | $39M | $35M | $27M | $22M | $16M | $16M | $9M | $8M | $8M | $6M | $6M | $6M | $7M | $6M | $5M | |
| Operating Expenses | $112M | $125M | $94M | $84M | $80M | $57M | $49M | $50M | $37M | $31M | $22M | $22M | $31M | $34M | $25M | $15M | |
| Operating Income | $-112M | $-125M | $-94M | $-84M | $-80M | $-57M | $-49M | $-50M | $-37M | $-31M | $-22M | $-22M | $-31M | $-34M | $-25M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | $2M | $2M | $943.0K | $914.0K | $874.0K | $599.0K | $147.0K | $128.0K | |
| Interest Income | $5M | $6M | $6M | $6M | $6M | $7M | $7M | $5M | $5M | $4M | $2M | $2M | $2M | $894.0K | $567.0K | $263.0K | |
| Other Non-op | $3M | $4M | $3M | $4M | $4M | $6M | $5M | $3M | $4M | $3M | $2M | $2M | $1M | $1M | $565.0K | $204.0K | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.0K | $0 | $0 | |
| Net Income | $-109M | $-121M | $-91M | $-80M | $-77M | $-52M | $-43M | $-47M | $-34M | $-28M | $-20M | $-20M | $-30M | $-32M | $-25M | $-15M | |
| EPS (Basic) | $-1.52 | $-1.69 | $-1.39 | $-1.26 | $-1.20 | $-0.81 | $-0.72 | $-0.85 | $-0.62 | $-0.56 | $-0.45 | $-0.46 | $-0.80 | $-1.18 | $-0.91 | $-0.55 | |
| EPS (Diluted) | $-1.52 | $-1.69 | $-1.39 | $-1.26 | $-1.20 | $-0.81 | $-0.72 | $-0.85 | $-0.62 | $-0.56 | $-0.45 | $-0.46 | $-0.80 | $-1.18 | $-0.91 | $-0.55 | |
| Shares (Basic) | 71,838,008 | 71,476,595 | · | 63,847,055 | 63,789,303 | 63,671,558 | · | 54,898,297 | 54,728,552 | 50,971,933 | 44,363,419 | 44,269,772 | 37,667,566 | · | 27,215,874 | 27,078,450 | |
| Shares (Diluted) | 71,838,008 | 71,476,595 | · | 63,847,055 | 63,789,303 | 63,671,558 | · | 54,898,297 | 54,728,552 | 50,971,933 | 44,363,419 | 44,269,772 | 37,667,566 | · | 27,215,874 | 27,078,450 | |
| EBITDA | $-112M | $-125M | · | $-84M | $-80M | $-57M | · | $-50M | $-37M | $-33M | $-22M | $-22M | $-32M | · | $-25M | $-15M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $114M | $355M | $58M | $49M | $55M | $93M | $27M | $25M | $69M | $27M | $34M | $137M | $43M | $30M | $50M | |
| Short-term Investments | $450M | $482M | $360M | $440M | $508M | $535M | $548M | $326M | $359M | $335M | $132M | $147M | $60M | $71M | $84M | $82M | |
| Prepaid Expense | $28M | $19M | $14M | $14M | $15M | $16M | $10M | $11M | $10M | $13M | $12M | $10M | $7M | $11M | $11M | $10M | |
| Other Current Assets | $4M | $2M | $3M | $1M | $2M | $2M | $1M | $1M | $429.0K | $568.0K | $2M | $1M | $883.0K | $719.0K | $792.0K | $776.0K | |
| Current Assets | $527M | $616M | $729M | $511M | $571M | $606M | $651M | $364M | $395M | $416M | $172M | $191M | $204M | $126M | $125M | $142M | |
| PP&E (Net) | $813.0K | $945.0K | $1M | $1M | $1M | $1M | $960.0K | $368.0K | $155.0K | $81.0K | $34.0K | $40.0K | $45.0K | $51.0K | $56.0K | $21.0K | |
| Other Non-current Assets | $5M | $6M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $533M | $622M | $735M | $518M | $579M | $610M | $656M | $369M | $397M | $419M | $176M | $195M | $210M | $131M | $131M | $149M | |
| Accounts Payable | $15M | $14M | $22M | $18M | $13M | $9M | $8M | $5M | $5M | $5M | $12M | $13M | $5M | $12M | $7M | $7M | |
| Accrued Liabilities | $34M | $31M | $31M | $23M | $20M | $11M | $16M | $20M | $12M | $7M | $10M | $11M | $16M | $11M | $6M | $8M | |
| Current Liabilities | $48M | $45M | $53M | $42M | $34M | $22M | $25M | $26M | $18M | $15M | $25M | $27M | $24M | $26M | $16M | $17M | |
| Capital Leases | · | · | $2M | $2M | $2M | $2M | $2M | $3M | $455.0K | $919.0K | $2M | $3M | $3M | $4M | $4M | $5M | |
| Other Non-current Liabilities | $2M | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $125M | $122M | $130M | $119M | $110M | $75M | $79M | $80M | $69M | $66M | $52M | $55M | $52M | $55M | $26M | $27M | |
| Long-term Debt | $75M | $75M | $75M | $75M | $74M | $51M | $51M | $50M | $50M | $50M | $25M | $25M | $25M | $25M | $5M | $5M | |
| Common Stock | $72.0K | $72.0K | $71.0K | $64.0K | $64.0K | $64.0K | $64.0K | $55.0K | $55.0K | $54.0K | · | · | · | $28.0K | · | · | |
| Retained Earnings | $-991M | $-882M | $-761M | $-670M | $-589M | $-513M | $-461M | $-418M | $-371M | $-337M | $-283M | $-263M | $-243M | $-213M | $-181M | $-156M | |
| AOCI | $-403.0K | $-156.0K | $786.0K | $881.0K | $527.0K | $654.0K | $393.0K | $1M | $-450.0K | $-173.0K | $-75.0K | $-142.0K | $-4.0K | $-224.0K | $-279.0K | $-152.0K | |
| Stockholders' Equity | $408M | $500M | $605M | $399M | $468M | $535M | $577M | $289M | $328M | $354M | $124M | $141M | $158M | $77M | $106M | $122M | |
| Liabilities + Equity | $533M | $622M | $735M | $518M | $579M | $610M | $656M | $369M | $397M | $419M | $176M | $195M | $210M | $131M | $131M | $149M |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $132.0K | $140.0K | $135.0K | $129.0K | $119.0K | $85.0K | $55.0K | $24.0K | $1M | $11.0K | $1M | $517.0K | $-506.0K | $-597.0K | $-152.0K | $-106.0K | |
| Stock-based Comp | $16M | $13M | $11M | $10M | $9M | $8M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-cash | · | $1M | · | · | · | $-11M | · | · | · | $-8M | · | · | $2M | · | · | · | |
| Operating Cash Flow | $-100M | $-106M | $-70M | $-62M | $-55M | $-54M | $-39M | $-37M | $-25M | $-34M | $-23M | $-18M | $-26M | $-21M | $-18M | $-19M | |
| CapEx | $0 | $23.0K | $102.0K | $133.0K | $208.0K | $187.0K | $645.0K | $238.0K | $89.0K | $0 | $0 | $0 | $0 | $0 | $38.0K | $6.0K | |
| Investing Cash Flow | $33M | $-138M | $81M | $70M | $29M | $15M | $-221M | $38M | $-23M | $-219M | $16M | $-86M | $12M | $13M | $-2M | $-42M | |
| Stock Repurchased | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $4M | $286M | $797.0K | $20M | $2M | $326M | $739.0K | $3M | $277M | $297.0K | $432.0K | $108M | $21M | $908.0K | $48.0K | |
| Net Change in Cash | $-65M | $-240M | $297M | $9M | $-6M | $-38M | $65M | $2M | $-44M | $23M | $-6M | $-104M | $94M | $13M | $-20M | $-61M | |
| Free Cash Flow | · | $-107M | · | · | · | $-55M | · | · | · | · | · | · | $-26M | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.7% | -19.7% | · | -18.1% | -15.7% | -10.0% | · | -17.1% | -11.4% | -9.0% | -13.1% | -11.7% | -16.1% | · | -22.2% | -12.0% | |
| ROE | -25.0% | -23.4% | · | -23.3% | -19.2% | -11.6% | · | -22.6% | -14.4% | -11.1% | -17.5% | -15.4% | -20.6% | · | -25.8% | -13.9% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 13.6 | · | 12.2 | 17.0 | 27.7 | · | 13.8 | 21.4 | 28.6 | 7.0 | 7.1 | 8.7 | · | 7.9 | 8.2 | |
| Quick Ratio | 10.3 | 13.2 | · | 11.9 | 16.6 | 26.9 | · | 13.4 | 20.9 | 27.8 | 6.5 | 6.7 | 8.4 | · | 7.2 | 7.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -19.5 | -16.3 | -23.1 | -24.0 | -35.8 | · | -171.7 | -117.6 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | · | $-1.49 | · | · | · | $-0.85 | · | · | · | $-0.66 | · | · | $-0.70 | · | · | · | |
| EPS (TTM) | $-5.86 | $-5.54 | · | $-3.99 | $-3.58 | $-3.00 | · | $-2.57 | $-2.17 | $-2.01 | $-2.89 | $-3.35 | $-3.44 | · | $-3.14 | $-2.59 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-402M | $-369M | · | $-252M | $-218M | $-175M | · | $-134M | $-108M | $-94M | $-103M | $-107M | $-102M | · | $-73M | $-56M | |
| P/E | -7.3 | -7.3 | · | -7.3 | -6.6 | -8.0 | · | -17.2 | -16.7 | -21.5 | -4.7 | -4.8 | -2.3 | · | -6.8 | -5.3 | |
| Earnings Yield | -13.7% | -13.8% | · | -13.7% | -15.2% | -12.5% | · | -5.8% | -6.0% | -4.7% | -21.1% | -20.9% | -44.3% | · | -14.7% | -19.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-300M | $-152M | $-96M | $-89M | $-33M |
| Verwässerte EPS | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 13.6 | 25.7 | 7.7 | 4.9 | 10.7 |
| Quick Ratio | 13.4 | 25.3 | 7.2 | 4.5 | 10.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-242M | $-136M | $-92M | $-68M | · |
Institutionelle Eigentümer (13F) 240 Einreicher · $3.4B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
240
Gehaltener Wert
$3.4B
Neue Positionen
34
Geschlossene Positionen
35
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 34 (-19 vs. Vorquartal) | 35 (+5 vs. Vorquartal) | 99 (+4 vs. Vorquartal) | 65 (+2 vs. Vorquartal) | +4.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $246.636.382 | 5.747.760 | 7,34% | Aktien |
| Avoro Capital Advisors LLC | $245.612.034 | 5.723.888 | 7,31% | Aktien |
| VANGUARD GROUP INC | $180.805.107 | 3.570.401 | 5,38% | Aktien |
| STATE STREET CORP | $178.024.407 | 4.148.786 | 5,30% | Aktien |
| Deep Track Capital, LP | $171.640.000 | 4.000.000 | 5,11% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $168.052.724 | 3.916.400 | 5,00% | Aktien |
| Kynam Capital Management, LP | $124.012.432 | 2.890.059 | 3,69% | Aktien |
| MORGAN STANLEY | $120.124.806 | 2.799.459 | 3,57% | Aktien |
| Sofinnova Investments, Inc. | $119.889.982 | 2.793.987 | 3,57% | Aktien |
| FMR LLC | $119.035.323 | 2.774.070 | 3,54% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $118.234.772 | 2.755.413 | 3,52% | Aktien |
| Eversept Partners, LP | $94.949.961 | 2.212.770 | 2,82% | Aktien |
| Logos Global Management LP | $94.402.000 | 2.200.000 | 2,81% | Aktien |
| Integral Health Asset Management, LLC | $75.092.500 | 1.750.000 | 2,23% | Aktien |
| Bellevue Group AG | $73.410.771 | 1.710.808 | 2,18% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $72.637.914 | 1.692.442 | 2,16% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $64.007.660 | 1.591.043 | 1,90% | Aktien |
| GOLDMAN SACHS GROUP INC | $59.251.630 | 1.380.835 | 1,76% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $55.585.829 | 1.295.405 | 1,65% | Aktien |
| Pictet Asset Management Holding SA | $53.625.486 | 1.249.414 | 1,60% | Aktien |
| DEUTSCHE BANK AG\ | $47.291.369 | 1.102.106 | 1,41% | Aktien |
| Qube Research & Technologies Ltd | $46.479.211 | 1.083.179 | 1,38% | Aktien |
| Woodline Partners LP | $42.954.498 | 1.001.037 | 1,28% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $37.170.604 | 866.243 | 1,11% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $27.585.680 | 642.873 | 0,82% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $27.572.336 | 642.562 | 0,82% | Aktien |
| GREAT POINT PARTNERS LLC | $25.781.873 | 600.836 | 0,77% | Aktien |
| BANK OF AMERICA CORP /DE/ | $25.321.319 | 590.103 | 0,75% | Aktien |
| NORTHERN TRUST CORP | $24.936.117 | 581.126 | 0,74% | Aktien |
| BRAIDWELL LP | $24.232.307 | 564.724 | 0,72% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $23.386.508 | 545.013 | 0,70% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $22.650.172 | 527.853 | 0,67% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $22.040.459 | 510.787 | 0,66% | Aktien |
| Davern Capital Partners, LP | $21.404.881 | 498.832 | 0,64% | Aktien |
| Candriam S.C.A. | $20.066.803 | 468.099 | 0,60% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $19.987.778 | 465.807 | 0,59% | Aktien |
| Elmind Capital, LP | $18.730.987 | 436.518 | 0,56% | Aktien |
| Rock Springs Capital Management LP | $18.347.629 | 427.584 | 0,55% | Aktien |
| Balyasny Asset Management L.P. | $16.089.147 | 374.951 | 0,48% | Aktien |
| ORBIMED ADVISORS LLC | $15.859.364 | 369.596 | 0,47% | Aktien |
| Ikarian Capital, LLC | $13.302.100 | 310.000 | 0,40% | Aktien |
| ARMISTICE CAPITAL, LLC | $12.873.000 | 300.000 | 0,38% | Aktien |
| Nuveen, LLC | $12.804.773 | 298.410 | 0,38% | Aktien |
| READYSTATE ASSET MANAGEMENT LP | $12.663.342 | 295.114 | 0,38% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $11.994.546 | 279.528 | 0,36% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $11.957.215 | 278.658 | 0,36% | Aktien |
| CITIGROUP INC | $11.446.585 | 266.758 | 0,34% | Aktien |
| UBS Group AG | $10.906.950 | 254.182 | 0,32% | Aktien |
| Affinity Asset Advisors, LLC | $10.727.500 | 250.000 | 0,32% | Aktien |
| Alphabet Inc. | $10.352.638 | 241.264 | 0,31% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Sofinnova Venture Partners X, L.P. ("SVP X"), Sofinnova Management X, L.P. ("SM X LP"), Sofinnova Management X-A, L.L.C. ("SM X LLC"), Dr. James I. Healy ("Healy"), Dr. Maha Katabi ("Katabi") | 5. März 2026 | 4,00% | Änderung | Passive Anlage | SEC |
| Longitude Capital Partners IV, LLC, Longitude Venture Partners IV, L.P., Longitude Prime Partners, LLC, Longitude Prime Fund, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×5 Einreichungen | 4. November 2024 | · | Erste Einreichung | · | SEC |
| Sofinnova Venture Partners X, L.P. (“SVP X”), Sofinnova Management X, L.P. (“SM X LP”), Sofinnova Management X-A, L.L.C. (“SM X LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) ×5 Einreichungen | 26. März 2024 | · | Erste Einreichung | Passive Anlage | SEC |
| Abingworth LLP, Abingworth Bioventures 8, LP ×2 Einreichungen | 7. April 2022 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 25 Insider · 12 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Marshall Fordyce | PRESIDENT AND CEO | 15. September 2026 M | 235.244 | 0 | 22 | $-9.730.927 |
| Sean Grant | CHIEF FINANCIAL OFFICER | 23. Februar 2026 S | 114.181 | 0 | 1 | $-207.759 |
| David Lee Johnson | Chief Operating Officer | 23. Februar 2026 S | 45.727 | 0 | 1 | $-108.266 |
| Joseph R Young | SVP, FINANCE, CHIEF ACCT OFFCR | 11. September 2026 M | 80.754 | 0 | 2 | $-566.752 |
| Nancy Lee Boman | Chief Regulatory Officer | 3. August 2026 A | 44.987 | 0 | 0 | $0 |
| Jane Wright Mitchell | Chief Legal Officer | 23. März 2026 A | 42.403 | 0 | 0 | $0 |
| Laurence Matthew Skelton | Chief Commercial Officer | 23. Februar 2026 S | 64.218 | 0 | 1 | $-66.412 |
| Robert Brenner | Chief Medical Officer | 23. Februar 2026 S | 50.947 | 0 | 1 | $-90.299 |
| William D. Turner | Chief Regulatory Officer | 23. Februar 2026 S | 45.313 | 0 | 4 | $-1.445.710 |
| Jason S Carter | Chief Legal Officer | 21. November 2025 S | 49.136 | 0 | 1 | $-107.496 |
| Celia Lin | Chief Medical Officer | 21. August 2023 S | 11.010 | 0 | 0 | $0 |
| Joanne Curley | Chief Development Officer | 21. August 2023 S | 26.962 | 0 | 0 | $0 |
| Kimball Hall | Direktor | 21. Mai 2026 A | · | 0 | 0 | $0 |
| Christy J. Oliger | Direktor | 21. Mai 2026 A | · | 0 | 0 | $0 |
| Andrew Cheng | Direktor | 21. Mai 2026 A | 17.488 | 0 | 0 | $0 |
| Scott W Morrison | Direktor | 21. Mai 2026 A | · | 0 | 0 | $0 |
| Michael Morrissey | Direktor | 21. Mai 2026 A | · | 0 | 0 | $0 |
| Beth C Seidenberg | Direktor | 21. Mai 2026 A | 131.553 | 0 | 0 | $0 |
| Christopher Hite | Direktor | 5. März 2026 A | · | 0 | 0 | $0 |
| Dr. Maha Katabi | Direktor | 14. Mai 2025 A | 2.793.987 | 0 | 0 | $0 |
| Kurt Von Emster | Direktor | 18. Mai 2021 C | 2.960.231 | 0 | 0 | $0 |
| COMMODORE CAPITAL LP | 10%-Eigentümer | 10. Januar 2024 S | 4.400.000 | 0 | 0 | $0 |
| Abingworth LLP | 10%-Eigentümer | 13. Mai 2021 A | 2.960.231 | 0 | 0 | $0 |
| James R Meyers | · | 21. Mai 2026 A | · | 0 | 0 | $0 |
| Patrick G. Enright | · | 21. Mai 2026 A | 5.882 | 1 | 0 | $249.985 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 32 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,63% | 9.072 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,58% | 89.811 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,16% | 1.227 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,16% | 68.530 SH | 19. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,15% | 5.108 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,15% | 447.454 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,14% | 601.982 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,08% | 367.755 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,07% | 1.634.337 SH | 11. September 2026 | Täglich |
| BKSE · BNY Mellon ETF Trust | 0,07% | 1.841 NS | 31. Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 14.351 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,07% | 30.600 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,06% | 16.721 SH | 11. September 2026 | Täglich |
| ESML · iShares Trust | 0,05% | 45.356 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 25.265 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,03% | 145.920 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 759.354 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 128.886 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 20.305 SH | 2. Oktober 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 20.341 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2.757 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 5.214 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 5.306 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 92.764 SH | 11. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 10.449 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 39.169 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 15.089 SH | 10. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 7.498 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.934.442 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.315 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 2.430 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 63.574 SH | 11. September 2026 | Täglich |
VERA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 20 Analysten
KAUF
Median-Ziel
$81.50
+175,7%
7 35,0%
Starker Kauf
11 55,0%
Kauf
2 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
14 Analysten · 2026-10-01Mittelwert-Ziel $77.50 +162,2%
← Unter allen Zielen
Aktueller Preis $29.56
Tief$34.00
Mittelwert$77.50
Hoch$100.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VERA | · | -10.9 | · | · | -55.9% | · |
| SLS | $577M | -15.1 | · | · | -55.4% | · |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | · |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | · |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | · |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 10, 2026